Author/Authors :
Haji Aghajani, Mohammad Prevention of Cardiovascular Disease Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Miri, Reza Department of Cardiology - School of Medicine - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Sistanizad, Mohammad Department of Clinical Pharmacy - School of Pharmacy - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Toloui, Amirmohammad Physiology Research Center - Iran University of Medical Sciences, Tehran, Iran , Madani Neishaboori, Arian Physiology Research Center - Iran University of Medical Sciences, Tehran, Iran , Pourhoseingholi, Asma Prevention of Cardiovascular Disease Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Asadpoordezaki, Ziba Department of Psychology - Maynooth University, Kildare, Ireland , Sadeghi, Roxana Department of Cardiology - School of Medicine - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Yousefifard, Mahmoud Pediatric Chronic Kidney Disease Research Center - Tehran University of Medical Sciences, Tehran, Iran
Abstract :
Introduction: The available literature regarding the rate of readmission of COVID-19 patients after discharge
is rather scarce. Thus, the aim in the current study was to evaluate the readmission rate of COVID-19 patients
and the components affecting it, including clinical symptoms and relevant laboratory findings. Methods: In this
retrospective cohort study, COVID-19 patients who were discharged from Imam Hossein hospital, Tehran, Iran,
were followed for six months. Data regarding their readmission status were collected through phone calls with
COVID-19 patients or their relatives, as well as hospital registry systems. Eventually, the relationship between
demographic and clinical characteristics and readmission rate was assessed. Results: 614 patients were entered
to the present study (mean age 58.7±27.2 years; 51.5% male). 53 patients were readmitted (8.6%), of which 47 pa-
tients (7.6%) had a readmission during the first 30 days after discharge. The reasons for readmission were relapse
of COVID-19 symptoms and its pulmonary complications in 40 patients (6.5%), COVID-19 related cardiovascu-
lar complications in eight patients (1.3%), and non-COVID-19 related causes in five patients (0.8%). Older age
(OR=1.04; 95% CI: 1.01, 1.06; p=0.002) and increased mean arterial pressure during the first admission (OR=1.04;
95% CI: 1.01, 1.08; p=0.022) were found to be independent prognostic factors for the readmission of COVID-19
patients. Conclusion: Readmission is relatively frequent in COVID-19 patients. Lack of adequate hospital space
may be the reason behind the early discharge of COVID-19 patients. Hence, to reduce readmission rate, extra
care should be directed towards the discharge of older or hypertensive patients.
Keywords :
Patient readmission , prognosis , follow-up studies , COVID-19